Poor Jobs Report Bo...
Health Care: Drugs
Applied DNA Sciences Inc. (APDN: OTC)
$0.05 0.00 | 1.96%
06/04/12 - 10:39 AM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.05 |
| 52 Week High | 0.10 |
| 52 Week Low | 0.05 |
| Avg. Daily Vol. (Mil) | 0.24 |
| Beta (3 year) | 1.16 |
| Share Related Items | |
| Mkt Cap (Mil) | 30.16 |
| Shares Out (Mil) | 591.41 |
| Float (Mil) | 344.39 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.80 |
| Current Ratio | 1.90 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.31 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 19.51 |
| Price/Book | 37.06 |
| Price/Cash Flow | -3.80 |
| Per Share Data | |
| Earnings | -0.02 |
| Sales | 0.00 |
| Book Value | 0.00 |
| Cash Flow | -0.01 |
| Business Summary | |
|---|---|
| The Company is a provider of botanical-DNA based security and authentication solutions that could help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. | |
| General Information | |
| 25 Health Sciences Drive
Suite 113 Stony Brook, NY 11790 |
|
| www.adnas.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 22 | |
| CEO: Dr. James A. Hayward | |
| Short Interest | |
| Current Month (Mil) | 0.00 |
| Previous Month (Mil) | 0.00 |
| Short Interest Ratio (Days) | 0.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -724.90 |
| Return on Investments | -129.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with APDN
- Portfolio NameUser Type
- UserTraverseman Portfolio 1
Latest APDN Headlines from TheStreet
Press Releases for APDN
Partner Headlines for APDN
- Applied DNA Initiated at Outperform - Analyst Blog - Zacks 09.03.10 | 04:09 pm
